Assessment of Knowledge and Attitudes of Young Uninsured Women toward Human Papillomavirus Vaccination and Clinical Trials

Journal of Pediatric and Adolescent Gynecology

Volumn 19, Issue 2, 2006, Pages 81-87

  Moreira Jr , Edson Duarte ^a,b,c   de Oliveira, Bruno Gusmão ^a,b   Neves, Raimundo Celestino Silva ^b   Costa, Sandra ^d   Karic, Gisela ^d   Filho, José Otávio Costa ^d  

^a Associacao Obras Sociais Irma Dulce   (Brazil)

^b INSTITUTO OSWALDO CRUZ   (Brazil)

^c HOSPITAL SÃO RAFAEL   (Brazil)

^d Sharp and Dohme Corp   (Brazil)

Author keywords

Cervical cancer; Genital warts; Human Papillomavirus (HPV); Knowledge; Pap smear screening; Vaccination

Indexed keywords

WART VIRUS VACCINE;

ADOLESCENT; ADULT; ARTICLE; ATTITUDE; BRAZIL; CLINICAL TRIAL; CONDYLOMA; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DATA ANALYSIS; FEMALE; GYNECOLOGICAL EXAMINATION; HEALTH INSURANCE; HUMAN; MEDICAL INFORMATION; OUTPATIENT; POPULATION RESEARCH; PREVALENCE; PRIORITY JOURNAL; QUESTIONNAIRE; SAMPLING; SEXUAL BEHAVIOR; UTERINE CERVIX CANCER; VACCINATION; WOMEN'S HEALTH;

EID: 33646484542     PISSN: 10833188     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jpag.2006.01.003     Document Type: Article

References (28)

1. Koutsky L. Epidemiology of genital human papillomavirus infection. Am J Med 102 (1997) 3
2. Moscicki A.B. Human papillomavirus infection in adolescents. Pediatr Clin North Am 46 (1999) 783
3. Dillner J., Meijer C.J., von Krogh G., and Horenblas S. Epidemiology of human papillomavirus infection. Scand J Urol Nephrol Suppl (2000) 194
4. Franceschi S., Castellsague X., Dal Maso L., et al. Prevalence and determinants of human papillomavirus genital infection in men. Br J Cancer 86 (2002) 705
5. Villa L.L. Human papillomaviruses and cervical cancer. Adv Cancer Res 71 (1997) 321
6. zur Hausen H. Molecular pathogenesis of cancer of the cervix and its causation by specific human papillomavirus types. Curr Top Microbiol Immunol 186 (1994) 131
7. Ho G.Y., Palan P.R., Basu J., et al. Viral characteristics of human papillomavirus infection and antioxidant levels as risk factors for cervical dysplasia. Int J Cancer 78 (1998) 594
8. Kotloff K.L., Wasserman S.S., Russ K., et al. Detection of genital human papillomavirus and associated cytological abnormalities among college women. Sex Transm Dis 25 (1998) 243
9. Nobbenhuis M.A., Walboomers J.M., Helmerhorst T.J., et al. Relation of human papillomavirus status to cervical lesions and consequences for cervical-cancer screening: a prospective study. Lancet 354 (1999) 20
10. Moscicki A.B., Shiboski S., Broering J., et al. The natural history of human papillomavirus infection as measured by repeated DNA testing in adolescent and young women. J Pediatr 132 (1998) 277
11. McNeil C. HPV vaccine treatment trials proliferate, diversify. J Natl Cancer Inst 89 (1997) 280
12. Hines J.F., Ghim S.J., and Jenson A.B. Prospects for human papillomavirus vaccine development: emerging HPV vaccines. Curr Opin Obstet Gynecol 10 (1998) 15
13. Villa L.L., Costa R.L., Petta C.A., et al. Prophylactic quadrivalent human papillomavirus (types 6, 11, 16, and 18) L1 virus-like particle vaccine in young women: a randomised double-blind placebo-controlled multicentre phase II efficacy trial. Lancet Oncol 6 (2005) 271
14. Suzich J.A., Ghim S.J., Palmer-Hill F.J., et al. Systemic immunization with papillomavirus L1 protein completely prevents the development of viral mucosal papillomas. Proc Natl Acad Sci U S A 92 (1995) 11553
15. Kirnbauer R. Papillomavirus-like particles for serology and vaccine development. Intervirology 39 (1996) 54
16. Lacey C.J., Thompson H.S., Monteiro E.F., et al. Phase IIa safety and immunogenicity of a therapeutic vaccine, TA-GW, in persons with genital warts. J Infect Dis 179 (1999) 612
17. Borysiewicz L.K., Fiander A., Nimako M., et al. A recombinant vaccinia virus encoding human papillomavirus types 16 and 18, E6 and E7 proteins as immunotherapy for cervical cancer. Lancet 1996 (1523) 347
18. Koutsky L.A., Ault K.A., Wheeler C.M., et al. A controlled trial of a human papillomavirus type 16 vaccine. N Engl J Med 2002 (1645) 347
19. Zimet G.D., Fortenberry J.D., Fife K.H., et al. Acceptability of genital herpes immunization. The role of health beliefs and health behaviors. Sex Transm Dis 24 (1997) 555
20. Zimet G.D., Mays R.M., Winston Y., et al. Acceptability of human papillomavirus immunization. J Womens Health Gend Based Med 9 (2000) 47
21. Lazcano-Ponce E., Rivera L., Arillo-Santillan E., et al. Acceptability of a human papillomavirus (HPV) trial vaccine among mothers of adolescents in Cuernavaca, Mexico. Arch Med Res 32 (2001) 243
22. Bodenheimer Jr. H.C., Fulton J.P., and Kramer P.D. Acceptance of hepatitis B vaccine among hospital workers. Am J Public Health 76 (1986) 252
23. Liau A., Zimet G.D., and Fortenberry J.D. Attitudes about human immunodeficiency virus immunization: the influence of health beliefs and vaccine characteristics. Sex Transm Dis 25 (1998) 76
24. Lambert E.C. College students' knowledge of human papillomavirus and effectiveness of a brief educational intervention. J Am Board Fam Pract 14 (2001) 178
25. Yacobi E., Tennant C., Ferrante J., et al. University students' knowledge and awareness of HPV. Prev Med 28 (1999) 535
26. Ramirez J.E., Ramos D.M., Clayton L., et al. Genital human papillomavirus infections: knowledge, perception of risk, and actual risk in a nonclinic population of young women. J Womens Health 6 (1997) 113
27. Rosenthal S.L., Kottenhahn R.K., Biro F.M., et al. Hepatitis B vaccine acceptance among adolescents and their parents. J Adolesc Health 17 (1995) 248
28. Hoover D.R., Carfioli B., and Moench E.A. Attitudes of adolescent/young adult women toward human papillomavirus vaccination and clinical trials. Health Care Women Int 21 (2000) 375-391